glp-1/gcgr dual agonist GIPR/GLP-1R therapies for diabetes and weight loss– Chemistry, Physiology and Clinical application Understanding GLP-1 receptor agonists and
Description
There are many lawsuits against its manufacturer, Eli Lilly, claiming that the drug has caused severe side effects, including: Vision loss or changes Gastroparesis (stomach paralysis) Neuropathy with gastroparesis Intestinal blockage (often requiring surgery to repair) Cyclical vomiting Pancreatic cancer Necrotizing pancreatitis Esophageal injury with surgery Blood clots Has Zepbound Harmed You

This study investigated the association between GLP-1RA use and the risk of vestibular disorders

Dietitians NZ
(2022) Structural determinants of dual incretin receptor agonism by tirzepatide

Weight loss and engagement in a tirzepatide-supported digital obesity program: a four-arm patient-blinded retrospective cohort study

Diabetes 52 , 380386 (2003)
